Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
- PMID: 33259154
- PMCID: PMC7722690
- DOI: 10.1056/NEJMc2031670
Shedding of Viable SARS-CoV-2 after Immunosuppressive Therapy for Cancer
Figures
![Figure 1](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7722690/bin/NEJMc2031670_f1.gif)
Comment in
-
Impact of COVID-19 on Clinical Care and Research in Cancer Imaging: Where We Are Now.Radiol Imaging Cancer. 2021 Jan 22;3(1):e210003. doi: 10.1148/rycan.2021210003. eCollection 2021 Jan. Radiol Imaging Cancer. 2021. PMID: 33778764 Free PMC article. No abstract available.
Similar articles
-
Detection of SARS-CoV-2 viremia before onset of COVID-19 symptoms in an allo-transplanted patient with acute leukemia.Bone Marrow Transplant. 2021 Mar;56(3):716-719. doi: 10.1038/s41409-020-01059-y. Epub 2020 Sep 18. Bone Marrow Transplant. 2021. PMID: 32943755 No abstract available.
-
Prolonged viral shedding of SARS-CoV-2 in an immunocompromised patient.J Infect Chemother. 2021 Feb;27(2):387-389. doi: 10.1016/j.jiac.2020.12.001. Epub 2020 Dec 4. J Infect Chemother. 2021. PMID: 33328135 Free PMC article.
-
Characterization of asthma and risk factors for delayed SARS-CoV-2 clearance in adult COVID-19 inpatients in Daegu.Allergy. 2021 Mar;76(3):918-921. doi: 10.1111/all.14609. Epub 2020 Oct 18. Allergy. 2021. PMID: 33012003 Free PMC article. No abstract available.
-
Prolonged shedding of SARS-CoV-2 in COVID-19 infected hemodialysis patients.Ther Apher Dial. 2021 Jun;25(3):356-358. doi: 10.1111/1744-9987.13566. Epub 2020 Sep 1. Ther Apher Dial. 2021. PMID: 32713131 No abstract available.
-
Clinical challenges in cancer patients with COVID-19: Aging, immunosuppression, and comorbidities.Aging (Albany NY). 2020 Nov 24;12(23):24462-24474. doi: 10.18632/aging.104205. Epub 2020 Nov 24. Aging (Albany NY). 2020. PMID: 33232275 Free PMC article. Review.
Cited by
-
Clinical and virological features of SARS-CoV-2 Omicron variant-infected immunocompromised patients receiving immunosuppressive medications.BMC Infect Dis. 2024 Jul 25;24(1):736. doi: 10.1186/s12879-024-09633-1. BMC Infect Dis. 2024. PMID: 39060971 Free PMC article.
-
Immunogenicity and Safety of the Three-Dose COVID-19 Vaccine Regimen in Patients Receiving Renal Replacement Therapy: A Systematic Review and Meta-Analysis.Kidney Dis (Basel). 2024 Jan 19;10(2):107-117. doi: 10.1159/000536308. eCollection 2024 Apr. Kidney Dis (Basel). 2024. PMID: 38751793 Free PMC article. Review.
-
Age-specific nasal epithelial responses to SARS-CoV-2 infection.Nat Microbiol. 2024 May;9(5):1293-1311. doi: 10.1038/s41564-024-01658-1. Epub 2024 Apr 15. Nat Microbiol. 2024. PMID: 38622380 Free PMC article.
-
Characteristics and Outcomes of Stem Cell Transplant Patients during the COVID-19 Era: A Systematic Review and Meta-Analysis.Healthcare (Basel). 2024 Feb 23;12(5):530. doi: 10.3390/healthcare12050530. Healthcare (Basel). 2024. PMID: 38470640 Free PMC article. Review.
-
Causality between COVID-19 and multiple myeloma: a two-sample Mendelian randomization study and Bayesian co-localization.Clin Exp Med. 2024 Feb 24;24(1):42. doi: 10.1007/s10238-024-01299-y. Clin Exp Med. 2024. PMID: 38400850 Free PMC article.
References
-
- Centers for Disease Control and Prevention. Discontinuation of transmission-based precautions and disposition of patients with COVID-19 in healthcare settings (interim guidance). August 10, 2020. (https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-p...).
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous